Genomic Valley Biotech Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	4.94	8.44	1.65	27.23	0.71	2.08
Revenue Growth (YoY)	-14.97%	411.25%	-93.94%	3758.23%	-66.09%	-75.42%
Cost of Revenue	2.02	2.02	0	15.86	0.02	1.3
Gross Profit	2.92	6.42	1.65	11.37	0.68	0.78
Selling, General & Admin	1.46	1.24	0.42	1.54	1.44	0.9
Other Operating Expenses	0.9	0.79	1.06	1.04	2.44	1.07
Operating Expenses	2.39	2.05	1.51	2.66	5.25	4.01
Operating Income	0.53	4.37	0.14	8.71	-4.56	-3.23
Interest Expense	-	-	-0	-0	-0.43	-1.79
Interest & Investment Income	0.04	0.04	0	0.43	0.78	0
Other Non Operating Income (Expenses)	-0.08	-	0.01	-	-	-
EBT Excluding Unusual Items	0.49	4.41	0.15	9.13	-4.21	-5.02
Other Unusual Items	-	-	-	-2.64	4.19	-
Pretax Income	0.49	4.41	0.15	6.49	-0.02	-5.02
Income Tax Expense	0.85	0.85	-0	0.01	0.08	0.57
Net Income	-0.36	3.56	0.15	6.48	-0.09	-5.59
Net Income to Common	-0.36	3.56	0.15	6.48	-0.09	-5.59
Net Income Growth	-	2245.53%	-97.66%	-	-	-
Shares Outstanding (Basic)	3	3	3	3	3	3
Shares Outstanding (Diluted)	3	3	3	3	3	3
Shares Change (YoY)	-3.56%	0.24%	-0.70%	-1.79%	1.91%	0.41%
EPS (Basic)	-0.12	1.17	0.05	2.12	-0.03	-1.83
EPS (Diluted)	-0.12	1.17	0.05	2.12	-0.03	-1.83
EPS Growth	-	2240.00%	-97.64%	-	-	-
Free Cash Flow	-	0.18	-0.2	-7.79	-21.29	-0.95
Free Cash Flow Per Share	-	0.06	-0.07	-2.55	-6.84	-0.31
Gross Margin	59.09%	76.08%	99.78%	41.75%	96.53%	37.44%
Operating Margin	10.65%	51.78%	8.56%	31.99%	-646.85%	-155.37%
Profit Margin	-7.29%	42.19%	9.20%	23.81%	-13.24%	-268.67%
Free Cash Flow Margin	-	2.09%	-12.16%	-28.60%	-3017.82%	-45.45%
EBITDA	0.56	4.4	0.15	8.79	-3.72	-1.34
EBITDA Margin	11.39%	52.08%	9.22%	32.28%	-	-64.44%
D&A For EBITDA	0.04	0.03	0.01	0.08	0.84	1.89
EBIT	0.53	4.37	0.14	8.71	-4.56	-3.23
EBIT Margin	10.65%	51.78%	8.56%	31.99%	-	-155.37%
Effective Tax Rate	172.81%	19.33%	-	0.09%	-	-
Revenue as Reported	4.9	8.48	1.67	27.65	1.55	2.11
Advertising Expenses	-	0.03	0.04	0.04	0.04	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.